Simplify Asset Management »

Sab Biotherapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $779k 208k 3.74

More positions owned by Simplify Asset Management

Simplify Exchange Traded Fun Government Money (SBIL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Simplify Exchange Traded Fun Us Eqt Pls Upsid (SPUC)
Simplify Exchange Traded Fun Multi Qis Altern (QIS)
Simplify Exchange Traded Fun Natl Muni Bd Etf (NMB)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Simplify Exchange Traded Fun Next Intangible (NXTI)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Regeneron Pharmaceuticals (REGN)
Amgen (AMGN)
Align Technology (ALGN)

View all positions for Simplify Asset Management

Top funds holding Sab Biotherapeutics

Vivo Capital
Commodore Capital
RA Capital Management
Woodline Partners
Sessa Capital IM
Vanguard Group
BVF
Propel Bio Management
Leucadia National Corporation
HB Wealth Management
Marshall Wace
Simplify Asset Management
AWM Investment Company
Stempoint Capital
Geode Capital Management

View all funds holding Sab Biotherapeutics